FCGR1A and acute myeloid leukemia: The results showed that components of the Spt-Ada-Gcn5-acetyltransferase complex and the molecule CD64 are potential biomarkers for DN T cell therapy, and activation of CD64 might help improve the efficacy of DN T cell therapy in AML (103).